Aplagon Oy

Peripheral Arterial Disease

Clinical research in peripheral arterial occlusive disease and peripheral arterial occlusive disease (PAOD), with a focus on blood flow impairment in the lower limbs.

  • Peripheral arterial occlusive disease
  • Peripheral arterial occlusive disease (PAOD)

The sponsor’s work in this area centers on vascular conditions associated with reduced arterial perfusion and limb ischemia.

Critical Limb Ischemia

Research activity includes critical limb ischemia and chronic limb-threatening ischemia (CLTI), reflecting a strong therapeutic interest in severe limb ischemic disease.

  • Critical limb ischemia
  • Chronic limb-threatening ischemia

These studies address advanced vascular disease characterized by threatened tissue viability and high risk of limb loss.

Antithrombotic Therapy

The sponsor investigates antiplatelet and anticoagulant approaches aimed at improving outcomes in ischemic limb disease.

  • Antiplatelet treatment
  • Anticoagulant treatment
  • Antithrombotic therapy

This therapeutic domain is closely linked to prevention of thrombotic complications in patients with compromised arterial circulation.

Endovascular Revascularization

Clinical studies also involve patients undergoing endovascular revascularization, with attention to peri-procedural vascular care in limb-threatening ischemia.

  • Endovascular revascularization
  • Periprocedural vascular treatment

This area reflects interest in supporting arterial intervention settings where restoration of blood flow is central to treatment.

Vascular Imaging and Distribution Studies

Research includes PET imaging and biodistribution assessment in PAOD and critical limb ischemia, alongside evaluation in healthy volunteers.

  • PET imaging
  • Biodistribution
  • Healthy volunteers

These investigations support understanding of vascular targeting and tissue distribution in ischemic limb disease.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of APAC (antiplatelet, anticoagulant) treatment in patients with peripheral arterial disease and chronic limb-threatening ischemia during blood vessel restoration procedure

    Recruiting

    2 1 1 1
    Investigated diseases:
    Finland